Loading...
XJPX
3141
Market cap4.22bUSD
Nov 26, Last price  
3,160.00JPY
Name

Welcia Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:3141 chart
P/E
43.86
P/S
0.51
EPS
72.05
Div Yield, %
1.11%
Shrs. gr., 5y
-0.16%
Rev. gr., 5y
8.16%
Revenues
1.29t
+5.56%
198,928,000,000238,752,000,000270,816,000,000293,378,000,000334,393,000,000380,461,000,000528,402,000,000623,163,000,000695,268,000,000779,148,000,000868,280,000,000949,652,000,0001,025,947,000,0001,144,278,000,0001,217,339,000,0001,285,005,000,000
Net income
14.96b
-43.45%
2,154,000,0003,524,000,0004,544,000,0005,899,000,0007,669,000,0007,454,000,0009,527,000,00014,451,000,00017,166,000,00017,423,000,00022,802,000,00027,999,000,00026,453,000,00027,030,000,00026,451,000,00014,957,000,000
CFO
47.85b
+2.83%
5,466,000,00013,245,000,00011,635,000,0007,924,000,00030,447,000,00016,519,000,00015,031,000,00033,303,000,00035,902,000,00034,872,000,00070,156,000,00046,396,000,00016,228,000,00060,296,000,00046,529,000,00047,845,000,000
Dividend
Aug 28, 20250 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Welcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores primarily sell OTC, healthcare/nursing care, baby, and health food products, as well as dispensing, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services. In addition, it rents and sells welfare equipment; and provides housing services for elderly people. As of February 28, 2022, the company operated 2,468 stores. Welcia Holdings Co., Ltd. was incorporated in 2008 and is headquartered in Tokyo, Japan. Welcia Holdings Co., Ltd. is a subsidiary of Aeon Co., Ltd.
IPO date
Sep 01, 2008
Employees
14,865
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑022024‑022023‑022022‑022021‑022020‑022019‑022018‑022017‑022016‑02
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT